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Accuracy of duplex sonography scans after renal
artery stenting
Shawn H. Fleming, MD, Ross P. Davis, MD, Timothy E. Craven, MSPH, Joel K. Deonanan, MD,
Christopher J. Godshall, MD, and Kimberley J. Hansen, MD, Winston-Salem, NC
Purpose: Reports of duplex sonography scan criteria for recurrent renal arterial (RA) stenosis after endoluminal stenting
have suggested that criteria for native arteries may overestimate recurrent disease. This retrospective report examines the
utility of renal duplex sonography (RDS) scans to define the presence of significant (ie, >60%) renovascular disease
(RVD) after percutaneous angioplasty and endoluminal stenting (PTAS).
Methods: Demographic, duplex, and angiographic data were reviewed and compared. RDS was obtained. Peak systolic
velocities (PSV) were obtained after PTAS from multiple sites along the main RA from both anterior and flank
approaches. Comparable images from digital subtraction angiography were independently examined for restenosis.
Percent diameter stenosis was determined from the site of maximal stenosis compared with the normal RA distal to the
stent. Sensitivity and specificity were estimated and 95% confidence intervals (CIs) were computed after adjusting for
within patient “clustering” of observations applying native RA RDS criteria using angiography as the gold standard.
Receiver operating characteristic (ROC) curves were used to estimate the optimal RDS values for recurrent stenosis.
Results: FromOctober 2003 to June 2009, 49 patients had angiographic imaging after PTAS. There were 30 patients (18
women, 12 men; mean age, 71  9 years) provided technically adequate paired angiographic and RDS assessment after
PTAS for 66 RAs. Paired analysis was performed for 23 RAs after primary PTAS and 43 RAs after secondary treatment.
The prevalence of significant restenosis was 35% (23 of 66 RAs). RAs with greater than 60% diameter restenosis had
higher peak systolic velocity (PSV) compared to those without (2.48  1.15 millisecond vs 1.44  0.58 millisecond;
P< .001). Compared to angiography, RA-PSV>1.8 millisecond with distal RA turbulence demonstrated a sensitivity of
73% (95% CI, 54%, 91%), specificity of 80% (95% CI, 67%, 93%), and an overall accuracy of 77% (95% CI, 67%, 88%) with
a positive predictive value of 64% (95% CI, 46%, 82%). Optimal RDS value estimated by ROC curve resulted in RA-PSV
of 2.5 millisecond which was associated with a sensitivity of 59% (95% CI, 36%, 82%), specificity of 95% (95% CI, 89%,
100%), an accuracy of 83% (95% CI, 74%, 92%), and a positive predictive value of 87% (95% CI, 68%, 100%).
Conclusion: Renal duplex sonography has utility to detect significant restenosis after PTAS. RDS criteria for significant
native RA stenosis compare favorably with optimal RDS criteria for restenosis estimated by ROC curves. ( J Vasc Surg
2010;52:953-8.)Renal duplex sonography (RDS) scan has proven clin-
ical use in the management of atherosclerotic renovascular
disease (RVD). At our center, RDS is the screeningmethod
of choice for RVD contributing to hypertension and/or
excretory renal insufficiency (ie, ischemic nephropathy).1
RDS has also proven utility as an intraoperative completion
study after open operative repair.2 Moreover, RDS accu-
rately defines patency, restenosis, and occlusion in follow-
up after operative repair of RVD.3 In addition to evaluation
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doi:10.1016/j.jvs.2010.04.055for clinical disease, RDS has defined the prevalence of RVD
in a large, free-living group of elderly participants and
defined the rate of anatomic progression in this group on
follow-up.4
Despite the value of RDS in screening, intraoperative
assessment, and postoperative surveillance after open oper-
ative repair, recent studies have questioned the utility of
RDS after percutaneous angioplasty and endoluminal
stenting (PTAS) for RVD.5,6 These studies suggest that
velocity criteria accurate for native RVD are associated with
unacceptable rates of false-positive studies when applied
after PTAS. Compliance change of the renal artery (RA)
wall after placement of an endoluminal stent is most fre-
quently cited for false-positive studies after PTAS. Several
studies exist examining this phenomenon in the carotid
literature, however, very little data are available regarding
duplex scan velocities after renal PTAS.
The specific aim of this study was to examine RDS
parameters that best correlate with hemodynamically sig-
nificant restenosis after RA PTAS defined by digital sub-
traction angiography (DSA).
METHODS
Patient population. All patients underwent RA-PTAS
for RA atherosclerosis and severe hypertension, with or with-
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subtraction angiograms that could be interpreted for reste-
nosis. Patients treated with RA-PTAS for fibromuscular
dysplasia were excluded from this study. The study was
conducted with the approval of the Wake Forest University
Health Sciences Institutional Review Board.
All procedures were performed by vascular surgeons at
Wake Forest University School of Medicine between Oc-
tober 2003 and June 2009. Procedural preparation, proce-
dural management, and follow-up for patients treated with
RA-PTAS at our center have been described in detail pre-
viously.1 Follow-up angiograms were performed during
intervention for restenosis (35%), contralateral RA inter-
vention (55%), or aortic endografting (10%). RDS was
performed before RA intervention and within 24 hours
after each RA-PTAS. Thereafter, routine RDS surveillance
was performed at 1-, 4-, and 6-month intervals.
Data collection and management. Patient demo-
graphics, comorbidities, and all relevant clinical informa-
tion were retrospectively collected from the electronic
medical records. A faculty vascular surgeon, blinded to the
study, reviewed all angiographic data in a retrospective
fashion for technical adequacy. Second and third individu-
als (vascular surgery fellows), blinded to the study, re-
viewed the images and calculated percent stenosis. Intra-
class correlation was calculated between the two observers.
RDS data, including peak systolic velocity (PSV), resistive
index, and kidney length were obtained from a prospec-
tively maintained database.
Renal angiography. All angiograms and RA-PTAS
were performed in a dedicated endosuite with a Siemens
Axiom Artis unit (Malvern, Pa). Anteroposterior and left
anterior oblique DSA was obtained with power injection
through a pigtail catheter placed at the level of the RAs. All
RVD was ostial in location and all RAs were stented pri-
marily with either Cordis Genesis (29), Boston Scientific
Biliary Express (Natick, Mass) (12), Boston Scientific Ex-
press (9), Transhepatic (4), Medtronic Racer (Santa Rosa,
Calif) (2) or Cordis Aviator (Warren, NJ) (1) stents deliv-
ered over a 0.014-inch balloon-tipped wire inflated to
provide distal embolic protection. Balloon-mounted stents
were sized to match the diameter of the normal RA distal to
the atherosclerotic lesion. Completion angiography was
performed with both pressure and hand injection. In 72 of
91 interventions, pullout pressures were obtained to iden-
tify residual pressure gradients consistent with residual ste-
nosis. Postprocessing of digital subtraction angiograms was
performed by one of two dedicated registered radiology
technologists and transferred to the electronic medical
record. Peak opacification and pixel shift functions were
used to maximize the RA contrast column. In peak opaci-
fication, several images (range, 2-6 images) from the source
contrast injection were combined. Temporal DSA was used
in all instances: mask images were obtained before contrast
injection at a rate of one image per second. These images
were then used as a reference for digital subtraction of bone
and soft tissue during the arteriogram.Degree stenosis was estimated from postprocessed an-
giograms using electronic calipers in IDXRAD software
(Burlington, Vt). Percent stenosis was estimated by com-
paring the diameter of the smallest contrast column with
the diameter of the normal lumen of the main RA distal to
the lesion.
Renal duplex sonography. Each patient underwent
RDS within 24 hours of the renal intervention, and again in
1, 4, and 6 months. Doppler ultrasound scan studies were
performed using a 5.2-MHz curvilinear probe with Dopp-
ler color flow, with either a Phillips IU22 (Phillips Health-
care, Andover, Mass) or an ATL HDI 5000 (Advanced
Technology Laboratories, Bothell, Wash) ultrasound scan
system using a previously described technique.1 PSV from
the aorta and RA were recorded. Restenosis was defined as
RA PSV 1.8 millisecond in a stented artery previously
documented as free of stenosis by completion angiography
and RDS after PTAS.
Statistical methods. Descriptive statistics (frequen-
cies and percentages for categorical characteristics; means,
and SDs of continuous characteristics) were computed for
patients included in evaluation of ultrasound scan predic-
tion of RA restenosis. Receiver operating characteristic
(ROC) curves were used to select an optimal cut point in
RA PSV to predict restenosis 60% diameter reduction of
stented renal arteries. Some contributedmultiple arteries to
the analyses; thus, methods were used to correct for poten-
tial within-subject correlation when calculating sensitivity
and specificity estimates.7 Proportional hazards regression
models were used to evaluate potential predictors of reste-
nosis after PTAS including 1- to 4-month postoperative
change in ipsilateral artery PSV as a potential predictor of
patency failure. All analyses were performed using SAS,
version 9.2, software (SAS Institute Inc, Cary, NC).
RESULTS
From October 2003 to June 2009, 49 patients had
angiographic imaging after PTAS. Thirty patients provided
technically adequate paired angiographic and RDS assess-
ment after PTAS for 66 RAs. Each of the archived images
were reviewed and interpreted for technical adequacy for
interpretation. Nineteen studies were omitted due to poor
contrast enhancement of the renal arteries (often studies
performed for other reasons such as lower extremity occlu-
sive disease), or inadequate projections for interpretation of
stenosis. Intraclass correlation was calculated between the
two image reviewers and found to be 85.7%. Demographic
data are summarized in the Table. Sixty percent of the
patients were male, 88% were white with an average age of
71 9 years. All patients had severe hypertension and were
on an average of 2.8 antihypertensive medications.
Last RA-PSV before PTAS averaged 2.75  0.97 mil-
liseconds. RA-PTAS measured within 24 hours after PTAS
averaged 1.44  0.83 milliseconds. RA-PSV within 24
hours after PTAS did not differ with the presence or ab-
sence of subsequent restenosis on follow-up (1.38  0.70
milliseconds vs 1.53  1.04 milliseconds; P  .650). The
average RA to aorta pressure gradient after PTAS was 0.4
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demonstrated zero gradients from RA to aorta for subjects
with comparative RDS and angiograms on follow-up.
Paired analysis for RDS compared to angiography was
performed for 23 RAs after primary PTAS and 43 RAs after
secondary treatment. All secondary treatments of restenosis
consisted of angioplasty alone (there were no instances of a
second stent placement). The prevalence of restenosis after
PTAS was 35% (23 of 66 RAs). All restenosis occurred
within the previously placed stent. There were two false-
negative results, both of which occurred in patients found
angiographically to have multiple renal arteries. RAs with
greater than 60% diameter restenosis had higher PSV com-
pared to those without (2.48 1.15milliseconds vs 1.44
0.58 milliseconds; P  .001). Fig 1 compares results from
RDS with DSA. Compared to angiography, RA-PSV1.8
milliseconds demonstrated a sensitivity of 73% (95% confi-
dence interval [CI], 54%, 91%), specificity of 80% (95% CI,
67%, 93%), and an overall accuracy of 77% (95% CI, 67%,
88%) with a positive predictive value of 64% (95% CI, 46%,
82%). RA-PSV 2.0 milliseconds demonstrated a sensitiv-
ity of 68% (95% CI, 51%, 85%), specificity of 80% (95% CI,
67%, 93%), an accuracy of 76% (95% CI, 66%, 85%), and a
positive predictive value of 63% (95% CI, 45%, 80%). Op-
timal RDS value estimated by ROC curve, demonstrated in
Fig 2, resulted in RA-PSV of 2.5 milliseconds which was
associated with a sensitivity of 59% (95% CI, 36%, 82%),
specificity of 95% (95% CI, 89%, 100%), an accuracy of 83%
(95% CI, 74%, 92%), and a positive predictive value of 87%
Table. Demographics
Variable No. (%)
Age, y 70.4
White race 44 (88)
Female 17 (34)
Smoking
Never 9 (18)
Former 23 (46)
Current 18 (36)
Diabetes 20 (40)
Stroke 15 (30)
Coronary artery disease 24 (48)
COPD 7 (14)
Left ventricular hypertrophy (ECG) 8 (16)
Preop creatinine 1.53
Antihypertensive agents 2.8
Preop renal artery PSV, cm/s 220
Preintervention medications
ACE inhibitor or ARB 14 (28)
Beta-blocker 36 (72)
Calcium channel blocker 32 (64)
Diuretic 26 (52)
Aspirin 39 (78)
Clopidogrel 10 (20)
Statin 25 (50)
ACE, Angiotensin converting enzyme;ARB, angiotensin II receptor block-
er;COPD, chronic obstructive pulmonary disease; ECG, electrocardiogram;
PSV, peak systolic velocity.(95% CI, 68%, 100%).Proportional hazard regression models failed to iden-
tify independent predictors of restenosis after PTAS for this
patient cohort.
DISCUSSION
Although widely applied, the blood pressure and renal
function benefit of RA PTAS for RVD is uncertain. Three
small prospective studies comparing best medical manage-
ment and PTAS failed to demonstrate a clear benefit from
intervention.8-10 Results from several large, ongoing ran-
domized clinical trials comparing PTAS and medical man-
agement are expected in the near future. In this regard, the
Angioplasty and Stent for Renal Artery Lesions (ASTRAL)
has been one of the first of these trials to provide published
results.11 This multicenter trial randomized 806 patients
with RVD to either primary renal PTAS or medical man-
agement. On median follow-up of 34 months, PTAS dem-
onstrated no benefit on the rate of renal function decline,
blood pressure, renal events, vascular events, or mortality.
Unfortunately, the ASTRAL trial did not report the rate of
Fig 1. Receiver operating characteristic curve for renal artery
peak systolic velocity (PSV) to predict recurrent 60% diameter
reducing restenosis. FN, False negative; TP, true positive.
Fig 2. Scatter plot for renal artery peak systolic velocity (PSV;
milliseconds) vs percent diameter reducing stenosis by angio-
graphy.restenosis among subjects randomized to PTAS.
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Doppler scan-derived velocities and recurrent arterial ste-
nosis after intra-arterial endoluminal stenting. After both
carotid and RA stenting, many reports indicate the velocity
criteria for native artery disease overestimate the presence of
significant stenosis after endoluminal stenting.12-21 The
most common explanation offered for this observation is a
decrease in the arterial wall compliance after stenting. This
explanation presumes that the energy that dilates the un-
stented vessel is expended as increased blood velocity
within the noncompliant stent.12 Contrary to this pre-
sumed increase in blood flow velocity, decreased vessel wall
compliance would be expected to increase the propagation
speed of the ultrasound scan in the stent. However, this
increased propagation speed should not affect the blood
flow velocity or its measurement because the latter is based
on the Doppler scan shifted signal from moving blood
elements. This alternative view is supported by Doppler
scan flow wire measurements with and without endolumi-
nal stents.22,23 Moreover, despite the compliance changes
associated with RA bypass and endarterectomy, we have
observed a high correlation between native RDS criteria for
intraoperative assessment and postoperative surveillance
compared with cut-film angiography.2
A potential limitation of this and many other studies
is the accuracy of the most common reference standard—
DSA. Angiography provides a two-dimensional image of a
three-dimensional structure. This limitation has been best
demonstrated by studies comparing intravascular ultra-
sound scan and stenting in the coronary circulation.24-27 In
addition, angiography provides a static anatomic image
without physiologic flow data. In the case of temporal DSA,
the digitally subtracted anatomic image of a diseased vessel
after PTAS can overestimate improvement compared with
physiologic assessment. This is especially true when post-
processing uses peak opacification and pixel shift func-
tions.28 Moreover, the influence of an endoluminal stent
on temporal digital subtraction techniques of luminal mea-
surement has been incompletely studied. Although the RA
motion with respiratory arrest is much less than seen in the
coronary circulation, retrospective misregistration artifacts
likely occur and may overestimate lumen diameters.
The experience described herein suggests the RDS
criteria for recurrent stenosis after PTAS are similar to those
for native RA disease. This view is shared by other authors
but certainly not all. Rocha-Singh et al29 in the Renal Artery
Stenting with Noninvasive Duplex Ultrasound Follow-up
(Renaissance) trial completed RDS in 93 subjects providing
comparative DSA from 36 within PTAS.29 Concordance
between RDS PSV 2.25 milliseconds or renal aortic
ration (RAR) 3.5 and 70% angiographic restenosis was
87%. By contrast, Chi et al6 reported on 67 consecutive
patients after PTAS with suspected restenosis based on
native RA criteria of PSV 2.0 milliseconds and RAR
3.5. Native RDS criteria were associated with angio-
graphic narrowing in only 46% of patients. Compared with
selective renal angiography using digital subtraction with
anteroposterior and left anterior views, ROC curves indi-cated that PSV 3.95 milliseconds or RAR 5.1 were the
most predictive of angiographic70% restenosis. It should
be noted that these authors did not report on ROC curves
for unstented atherosclerotic RA lesions; however, native
RDS criteria for these lesions correlated with angiographic
narrowing in only 55% of patients.
Many reports of RDS for both native disease and reste-
nosis after PTAS cite RAR as a discriminating criteria for
significant RA narrowing.6,30-32 The rationale first pro-
vided for RAR was that RA velocities reflected aortic veloc-
ities in combination with increased velocities associated
with narrowing in the RA.33 However, data from both
population-based studies and patient management have
demonstrated no correlation between aortic and RA PSV.1
Rather, the association between RA stenosis and RDS
resides entirely with PSV. Consequently, the RAR term
should be viewed as a spurious correlation rather than a
discriminating criteria for both native stenosis and resteno-
sis after PTAS.1
All studies published to date suffer from the well-
recognized limitation of verification bias. Studies to date
have performed the reference standard procedure (ie,
digital subtraction and/or computerized tomographic
angiography) based on the result of RDS.5,6 When the
reference standard procedure depends on the test of
investigation, a reliable estimate of diagnostic accuracy is
precluded. To obtain valid accuracy estimates of RDS
criteria, all subjects should undergo both RDS and an-
giography at predefined intervals regardless of the RDS
result. One or more of the ongoing randomized clinical
trials comparing PTAS with best medical management
may provide prospective cohort studies of both RDS and
angiography. In addition, the authors have begun a
prospective study that compares RDS, intravascular ul-
trasound scan, pullout pressures, and DSA before and
after PTAS for RVD.
Although our experience supports the notion that na-
tive RA RDS criteria have use after PTAS, our report has a
number of other limitations. In addition to verification
bias, physiologic assessment by arterial pressure measure-
ments was obtained only at completion of primary PTAS
and after re-angioplasty for restenosis. Pressure measures
were not routinely obtained before RA intervention. In
addition, angiography was only performed when RDS cri-
teria for restenosis was accompanied by worsening blood
pressure control or renal insufficiency. Angiography was
not repeated if the initial intervention was not associated
with blood pressure/renal function benefit or clinical ben-
efit wasmaintained despite a positive RDS result. This latter
practice may have reduced the number of false-positive
RDS studies.
In conclusion, this experience suggests that duplex
sonography scan has use after RA angioplasty and stenting
to define RA patency with and without restenosis. Native
criteria for restenosis compare favorably with optimal RDS
criteria for restenosis estimated by ROC curves.
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Dennis Bandyk, (Tampa, Fla). The vascular surgery group
from Wake Forrest University are experts in renal duplex ultra-
sound testing, and thus their recommendation of interpretation
criteria after renal artery stenting is welcomed. This retrospective
analysis of renal artery hemodynamics following stent angioplasty
concluded similar duplex criteria can be used to estimate stent
stenosis severity. The diagnostic accuracy of duplex testing was
evaluated by receiver-operator curve (ROC) analysis and optimal
velocity spectra criteria to detect a 60% stent stenosis were selected
based on the highest accuracy and positive predictive values. The peak
systolic velocity 2.5 m/s was associated with an accuracy of 83% and
positive predictive value of 87%.
The threshold velocity criteria to diagnose renal stent stenosis
depend on the goal of testing. If the goal is to all stenosis, then
criteria of a peak systolic velocity of 1.8 m/s, which yielding the
highest sensitivity would be used. But if the goal of testing is to
identify high-grade stent stenosis, which should be considered for
re-intervention or considered a “failed” intervention than values
yielding the highest positive predictive value should be used.
This study had strengths and weaknesses. A study strength was
that duplex studies were obtained prior to and immediately after renal
stenting and correlated with measured renal artery pressure gradients
in the majority of patients. Study weaknesses included a small patient
series and the absence of hemodynamic information on the functional
impact of an identified stenosis on hilar artery flow. I was somewhat
surprised the group does like the renal-aortic ratio as a diagnostic
parameter (althoughmeasurement of peak aorta velocitywas included
in the renal duplex scan protocol, especially since the recent study by
Mohabbat and associates (J Vasc Surg April 2009) recommended an
RAR of 4.5 because of its high (97%) diagnostic accuracy. After
reading this article, Iwondered if the bestdiagnostic criteria for stent
stenosis requiring consideration for reintervention in an individualpatient should be the renal PSV prior to intervention - in this study,
the renal stenosis mean renal PSV prior to stenting was 2.75 m/s -
very similar to the recommendation of 250 cm/s. Our group uses a
renal artery stent PSV of3.0 m/s as the threshold for consideration
of reintervention.
I have two questions for the authors: (1) Was the goal of
duplex testing to detect stent stenosis or to screen for a clinically
important stenosis, which would then guide decision-making for
additional testing or when to reintervene? and (2) Why not utilize
the RAR or assessment hilar artery velocity spectra parameters
(acceleration time, peak velocity) to determine the functional
significance of an identified renal artery stent stenosis. The use of
two diagnostic criteria would improve the positive predictive value
of renal duplex testing.
Dr Shawn H. Fleming. I think that in answer to the first
question, our goal for deciding on who to reintervene on, we did
not just use duplex criteria alone, we identified patients with
greater than 1.8 m/s as patients that potentially had restenosis but
in order to get an intervention, they also had to have demonstrated
clinical decline in either worsening hypertension or worsening
renal function. In addition to this, any patient can get reintervened
on also had to have responded clinically to prior intervention, so
while we use this cut point to define who may have restenosis, we
combine it with the clinical picture to decide who gets reintervened
on. In that sense, we feel that using a study with high sensitivity
would be best.
In response to your second question, atWake Forest, it has not
been our practice to use the renal-aortic ration as a determinant of
stenosis. This practice goes back to studies done at our institution
in the early 90s, where it was found that aortic velocities tend to be
sporadic and not particularly predictive of stenosis. We have found
that PSV alone has been a more accurate determinant of RAS.
